Limited effects of intravenous paracetamol on patent ductus arteriosus in very low birth weight infants with contraindications for ibuprofen or after ibuprofen failure

European Journal of Pediatrics

Volumn 174, Issue 11, 2015, Pages 1433-1440

  Roofthooft, Daniëlla W E ^a   van Beynum, Ingrid M ^a   de Klerk, Johan C A ^a   van Dijk, Monique ^a   van den Anker, John N ^a,b   Reiss, Irwin K M ^a   Tibboel, Dick ^a   Simons, Sinno H P ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Ibuprofen contraindication; Ibuprofen treatment failure; Paracetamol; Patent ductus arteriosus; VLBW infants

Indexed keywords

IBUPROFEN; PARACETAMOL; ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTERY LIGATION; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; INFANT; INFANT MORTALITY; MALE; OBSERVATIONAL STUDY; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; SINGLE DRUG DOSE; TREATMENT FAILURE; VERY LOW BIRTH WEIGHT; DUCTUS ARTERIOSUS, PATENT; GESTATIONAL AGE; INTRAVENOUS DRUG ADMINISTRATION; NEWBORN; PREMATURITY; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ACETAMINOPHEN; ADMINISTRATION, INTRAVENOUS; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COHORT STUDIES; DUCTUS ARTERIOSUS, PATENT; FEMALE; GESTATIONAL AGE; HUMANS; IBUPROFEN; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; MALE; PROSPECTIVE STUDIES; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84945497309     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-015-2541-5     Document Type: Article

References (29)

1. Alan S, Karadeniz C, Okulu E, Kilic A, Erdeve O, Ucar T, Atasay B, Atalay S, Arsan S (2013) Management of patent ductus arteriosus in preterm infants: clinical judgment might be a fair option. J Matern Fetal Neonatal Med 26:1850–1854
2. Allegaert K, Naulaers G (2010) Haemodynamics of intravenous paracetamol in neonates. Eur J Clin Pharmacol 66:855–858
3. Bouayad A, Kajino H, Waleh N, Fouron JC, Andelfinger G, Varma DR, Skoll A, Vazquez A, Gobeil F Jr, Clyman RI, Chemtob S (2001) Characterization of PGE2 receptors in fetal and newborn lamb ductus arteriosus. Am J Physiol Heart Circ Physiol 280:H2342–H2349
4. Bozdag SC, Tekgunduz E, Durgun G, Sarica A, Demiriz IS, Kocubaba S, Altuntas F (2013) Which regimen is better for stem cell mobilization of lymphoma patients? Transfus Apher Sci 48:407–410
5. Dang D, Wang D, Zhang C, Zhou W, Zhou Q, Wu H (2013) Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial. PLoS One 8:e77888
6. Dani C, Bertini G, Corsini I, Elia S, Vangi V, Pratesi S, Rubaltelli FF (2008) The fate of ductus arteriosus in infants at 23–27 weeks of gestation: from spontaneous closure to ibuprofen resistance. Acta Paediatr 97:1176–1180
7. Demiriz IS, Bozdag SC, Tekgunduz E, Ugur B, Durgun G, Kocubaba S, Altuntas F (2013) Predicting the successful peripheral blood stem cell harvesting. Transfus Apher Sci 48:411–414
8. El-Khuffash A, Jain A, Corcoran D, Shah PS, Hooper CW, Brown N, Poole SD, Shelton EL, Milne GL, Reese J, McNamara PJ (2014) Efficacy of paracetamol on patent ductus arteriosus closure may be dose dependent: evidence from human and murine studies. Pediatr Res 76:238–244
9. El-Khuffash A, James AT, Cleary A, Semberova J, Franklin O, Miletin J (2015) Late medical therapy of patent ductus arteriosus using intravenous paracetamol. Arch Dis Child Fetal Neonatal Ed
10. Evans N, Kluckow M (1996) Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed 75:F183–F186
11. Hammerman C, Bin-Nun A, Kaplan M (2012) Managing the patent ductus arteriosus in the premature neonate: a new look at what we thought we knew. Semin Perinatol 36:130–138
12. Hammerman C, Bin-Nun A, Markovitch E, Schimmel MS, Kaplan M, Fink D (2011) Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment. Pediatrics 128:e1618–e1621
13. Heubi JE, Barbacci MB, Zimmerman HJ (1998) Therapeutic misadventures with acetaminophen: hepatoxicity after multiple doses in children. J Pediatr 132:22–27
14. Kessel I, Waisman D, Lavie-Nevo K, Golzman M, Lorber A, Rotschild A (2014) Paracetamol effectiveness, safety and blood level monitoring during patent ductus arteriosus closure: a case series. J Matern Fetal Neonatal Med 27:1719–1721
15. Kluckow M, Evans N (2000) Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage. J Pediatr 137:68–72
16. Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR (2006) Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 117:1113–1121
17. Mandhan P, Brown S, Kukkady A, Samarakkody U (2009) Surgical closure of patent ductus arteriosus in preterm low birth weight infants. Congenit Heart Dis 4:34–37
18. Noori S, McCoy M, Friedlich P, Bright B, Gottipati V, Seri I, Sekar K (2009) Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics 123:e138–e144
19. Oncel MY, Yurttutan S, Degirmencioglu H, Uras N, Altug N, Erdeve O, Dilmen U (2013) Intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants. Neonatology 103:166–169
20. Oncel MY, Yurttutan S, Erdeve O, Uras N, Altug N, Oguz SS, Canpolat FE, Dilmen U (2014) Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial. J Pediatr 164:510–514, e511
21. Oncel MY, Yurttutan S, Uras N, Altug N, Ozdemir R, Ekmen S, Erdeve O, Dilmen U (2013) An alternative drug (paracetamol) in the management of patent ductus arteriosus in ibuprofen-resistant or contraindicated preterm infants. Arch Dis Child Fetal Neonatal Ed 98:F94
22. Patel J, Roberts I, Azzopardi D, Hamilton P, Edwards AD (2000) Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res 47:36–42
23. Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubaltelli FF (1999) Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr 135:733–738
24. Roofthooft DW, van Beynum IM, Helbing WA, Reiss IK, Simons SH (2013) Paracetamol for ductus arteriosus closure: not always a success story. Concerning the article by M. Y. Oncel et al.: intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants [Neonatology 2013; 103:166–169]. Neonatology 104:170
25. Shetty N, Patil AK, Ganeshkar SV, Hegde S (2013) Comparison of the effects of ibuprofen and acetaminophen on PGE2 levels in the GCF during orthodontic tooth movement: a human study. Prog Orthod 14:6
26. Sinha R, Negi V, Dalal SS (2013) An interesting observation of PDA closure with oral paracetamol in preterm neonates. J Clin Neonatol 2:30–32
27. Tekgunduz KS, Ceviz N, Demirelli Y, Olgun H, Caner I, Sahin IO, Yolcu C (2013) Intravenous paracetamol for patent ductus arteriosus in premature infants—a lower dose is also effective. Concerning the article by M. Y. Oncel et al.: intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants [Neonatology 2013; 103:166–169]. Neonatology 104:6–7
28. Van Eyken P, Nemolato S, Faa G, Ambu R (2012) Hepatic injury to the newborn liver due to drugs. Curr Pharm Des 18:3050–3060
29. Yurttutan S, Oncel MY, Arayici S, Uras N, Altug N, Erdeve O, Dilmen U (2013) A different first-choice drug in the medical management of patent ductus arteriosus: oral paracetamol. J Matern Fetal Neonatal Med 26:825–827